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Abstract
Background: Although checking specimen quality upon sputum collection for acid-fast smear of suspected
tuberculosis (TB) cases is recommended, this procedure is based on expert opinion. The purpose of this study was
to elucidate the impact of sputum gross appearance and volume on smear positivity among patients with
suspected pulmonary TB, according to sex.
Methods: From November 2010 through June 2011, we enrolled consecutive patients suspected to have active
pulmonary TB. The association of sputum gross appearance and volume with smear positivity, along with other
variables possibly affecting smear positivity such as symptoms, disease extent, and cavity on chest radiograph, were
investigated.
Results: Among 2,439 patients undergoing TB examination, 170 (113 men, 57 women) with active pulmonary TB
were enrolled. They submitted 492 sputa. There were 73 smear-positive patients (42.9%) and 164 smear-positive
sputa (33.3%). While gross appearance was associated with smear positivity in both sexes (purulent or blood-tinged
sputum (rather than mucoid sputum or saliva); odds ratio (OR), 2.05, 95% confidence interval (CI), 1.21–3.47 in men;
OR, 2.78, 95% CI, 1.23–6.26 in women), the amount of sputum specimens was associated with smear positivity in
only female patients (≥4 ml versus <4 ml; OR, 4.96, 95% CI, 1.98–12.37).
Conclusions: Sputum gross appearance and volume were associated with smear positivity. A volume of 4 ml
seems to be the the minimum sputum volume acceptable for smear microscopy in females suspected of TB. Those
suspected of TB should be encouraged to expectorate grossly qualified sputum specimens.
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Background
Tuberculosis (TB) remains a major public health prob-
lem, and the global burden of TB is enormous. In 2010,
8.8 million cases of TB were reported, with 1.1 million
deaths among those who were HIV-negative and an add-
itional 0.35 million deaths from HIV-associated TB [1].
To eradicate TB, early detection and treatment of
smear-positive pulmonary TB is a top priority. Smear
microscopy is still the most crucial test for the diagnosis
of pulmonary TB, especially in countries with limited
resources. Accordingly, smear microscopy quality assur-
ance has been emphasized in the WHO Directly
Observed Treatment Short Course (DOTS) strategy [2].
Besides smear microscopy quality assurance, the import-
ance of sputum specimen quality has been also sug-
gested. Sputum-submission instruction has been
reported to improve detection of smear-positive TB, es-
pecially in females suspected of TB [3-6].
However, although such instruction is proved to be
useful for optimizing the quality of sputum specimens,
at most half of instructed patients submitted adequate
sputum specimens [3,7,8]. Considering that WHO plans
to change the current “spot-morning” sputum submis-
sion to “spot-spot” sputum submission for smear
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microscopy [9,10] and that the smear positivity yield of
spot sputum is lower than that of morning sputum [11],
development of quality criteria that could guarantee spu-
tum specimens of adequate quality is crucial. Although
various kinds of quality criteria regarding specimen gross
appearance and volume [3-6,8,12-14] are recommended
to be checked upon collection, these criterias are based
not on a well-designed study, but on expert opinion
[15]. The purpose of this study was to elucidate the im-
pact of sputum specimen gross appearance and volume
on smear positivity in patients suspected to have pul-
monary TB, according to sex.
Methods
Subjects and sputum collection
From November 15, 2010 through June 30, 2011, we en-
rolled consecutive persons suspected to have active pul-
monary TB at eight primary public health centers in
Incheon City, Republic of Korea. Participants were asked
to submitted three sputum specimens, consisting of one
spot and two subsequent morning sputa. Prior to sub-
mission, they were instructed in detail concerning the
submission of adequate sputum specimens, including
the importance of sputum quality and how to expector-
ate properly. However, we did not mention a target vol-
ume. Persons with a history of previous TB treatment,
or who had received TB medication within the past
60 days, or who did not submit two morning sputa, were
excluded from the study. The study protocol was
approved by the institutional review board of Seoul Na-
tional University Hospital. Written informed consent
was obtained from all participants.
Sample size calculation
To calculate sample size, we reviewed the results of
acid-fast bacilli (AFB) smears between March 1, 2010
and August 30, 2011. Sputum volume was recorded as
≥3 or <3 ml. The difference in smear positivity between
saliva and mucoid or purulent specimens was 21.4%, and
that between sputum <3 and ≥3 ml was 17.6%. Based on
the above findings and allowing 5% for type I and 20%
for type II errors, the sample sizes estimated using the
generalized estimating equation (GEE) were 82 patients
for sputum appearance (correlation coefficient, 0.7186)
and 170 for sputum volume (correlation coefficient,
0.7089).
Collection of demographic and clinical characteristics
Demographic information and clinical characteristics
were collected using a questionnaire. The questionnaire
included demographic information (age, sex, history of
smoking) and clinical characteristics (respiratory symp-
toms such as cough, sputum, and hemoptysis, as well as
general symptoms including fever, night sweats, and
weight loss).
Radiographic evaluation
A posteroanterior chest radiograph was obtained using
digital radiography at 110–120 kVp and 2.5–4.0mAs.
Each chest radiograph was evaluated for the presence of
a cavity and categorized for TB extent into minimal,
moderate, and far-advanced, independently by two
board-certified radiologists [16]. Any discrepancies were
resolved by consensus between the two radiologists dur-
ing a subsequent review.
Sputum gross evaluation and volume determination
Two technicians independently evaluated the gross ap-
pearance and volume of sputum specimens. The gross
appearance of sputum specimens was classified into sal-
iva, mucoid, purulent, or blood-stained sputum [17].
The submitted specimens having clear and watery ap-
pearance without any viscosity was designated as saliva.
After the exclusion of saliva, the differentiation between
mucoid and purulent sputums was based on a five-point
sputum color chart (BronkoTest; Heredilab Inc., Salt
Lake City, UT, USA). Colors 1 and 2 were regarded as
mucoid and colors 3 to 5 as purulent sputum. The spu-
tum specimens having a pink to reddish color besides of
color chart was designated as blood-stained sputum. If
content of sputum specimens were heterogenous, a pre-
dominant portion was used to assess the quality of spu-
tum specimens. Specimen volume was assessed in
millimeters by comparing the gradation of a reference
container to the volume in the specimen container. Dis-
crepancies were resolved by consensus between the two
technicians.
AFB smear microscopy
Submitted sputa were examined microscopically for the
presence of AFB by Ziehl–Nielson staining at each pub-
lic health center. In addition, specimens were sent to the
local reference laboratory center (Korean National Tu-
berculosis Association, Incheon branch), which was in
charge of mycobacterial examinations in Incheon City.
In the case of smearing sputum specimens with inhomo-
genous content, the most purulent portion of sputum
specimens was sampled with platinum wire loop. Slides
were stained with Auramin-O stain and examined using
fluorescence microscopy by the chief technician, who
was blinded to the result of Ziehl–Nielson microscopy.
The participants were regarded as having smear-positive
pulmonary TB if the result of either Ziehl–Nielson or
fluorescence microscopy was one or more smears of
grade 1+ or higher (10–99 bacilli per 100 fields)(12).
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Mycobacterial culture and TB confirmation
The national reference standard quality-assured culture
was performed at the local reference laboratory center.
First (spot) and second (morning) sputum specimens
underwent solid culture (Ogawa media), and the third
(morning) sputum specimen underwent both solid cul-
ture (2% Ogawa media, Korean Institute of Tuberculosis,
Korea) and liquid culture (BACTEC MGIT (mycobac-
teria growth indicator tube) 960 culture; BD Microbiol-
ogy Systems, Sparks, MD, USA). Specimens were
decontaminated using 4% NaOH for solid culture, and
standard N-acetyl-L-cysteine–NaOH (2%) for liquid cul-
ture. The chief technician recorded the results of cul-
tures each Tuesday; cultures were designated negative if
colonies were absent after 8 weeks of incubation for
solid culture. Liquid cultures were observed for 6 weeks.
A diagnosis of TB was confirmed if either Mycobacter-
ium tuberculosis was isolated in at least one solid or li-
quid culture, or if clinical-radiological improvements
were achieved with anti-TB treatment.
Statistical analysis
The demographic and clinical characteristics and spu-
tum profiles of enrolled patients are presented as the
median with range or mean ± standard deviation, and
compared according to smear-positivity using Fisher’s
exact, chi-square, and Mann–Whitney tests for categor-
ical variables and Student’s t-test for continuous vari-
ables. Variables including gross appearance and volume
were evaluated to determine their associations with
smear positivity using univariate GEEs, with exchange-
able working correlations. After testing for multi-
collinearity among the variables using variance inflation
factors, multivariate models were conducted using com-
binations of variables that exhibited P values <0.05 in
the univariate analysis. The multivariate model for pre-
dicting smear positivity was judged to be optimized
when the quasi-likelihood under the independence
model criterion in GEE analysis showed the lowest value.
The association of sputum volume with smear positivity
was investigated after stratification according to sex not
only in all enrolled TB cases but also in culture con-
firmed TB cases. In addition, the association between
disease severity/smoking and volume of submitted spu-
tum was analyzed in both sexes to evaluate the impact
of possible confounders affecting the association be-
tween volume of sputum specimens and smear
positivity.
Inter-observer agreement regarding smear positivity
between public health centers and the local laboratory
center, radiographic evaluation between radiologists, and
sputum gross appearance and volume between techni-
cians was assessed with the κ statistic [18]. A κ value
<0.20 indicated poor agreement; a κ value of 0.21–0.40,
fair agreement; a κ value of 0.41–0.60, moderate agree-
ment; a κ value of 0.61–0.80, good agreement; and a κ
value of more than 0.81, excellent agreement.
Data were analyzed using the SPSS software package
(ver. 17.0; SPSS, Inc., Chicago, IL, USA). A two-sided
significance level of 5% was used for all analyses.
Results
Demographic and clinical characteristics
Among 2,439 patients undergoing a TB examination in
public health centers, a total of 263 patients were micro-
scopically or clinically diagnosed with pulmonary TB. Of
these, 74 patients who met the exclusion criteria or who
did not provide informed consent were excluded. In
addition, 19 patients diagnosed with nontuberculous
mycobacterial lung diseases or lung cancer were
excluded. Finally, 170 with pulmonary TB were included
and analyzed (Figure 1). Of these, 101 (59.4%) had
culture-positive TB and 69 (40.6%), clinically diagnosed
TB. One-hundred and thirteen (66.4%) were male. Their
median age was 44.0 years (range, 16–87 years). Ninety-
five (55.8%) patients were ever-smokers. A total of 113
Figure 1 Flow chart of the study group enrollment process.
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(66.4%) had one or more respiratory symptoms, most
commonly, cough and sputum. One-hundred one
patients (58.8%) had a minimal TB extent on their chest
radiographs; 50 (29.4%) had a moderate extent, and 19
(11.2%) had a severe extent. In addition, 41 (24.1%) had
cavitary lesions (Table 1).
AFB was observed in one or more sputum smears
from 73 (42.9%) patients (smear-positive TB), including
52 (46.0%) men and 21 (36.8%) women. Sputum culture
revealed M. tuberculosis in 101 (59.4%) patients, includ-
ing 71 men (62.8%) and 30 women (52.6%). Current
smokers were more common among male than female
patients with TB (45.1% vs. 8.8%; P < 0.001). Extent of
TB was wider (P= 0.009) and cavities were more com-
mon (P= 0.004) in men.
Sputum gross appearance and volume
A total of 170 patients submitted 492 sputa. Most (152,
89.4%) submitted one spot and two subsequent morning
sputa. Mucoid (42.3%) and purulent (33.3%) sputa were
common, and the median sputum volume was 3.0 ml
(range, 1.0–8.0 ml). The distribution of gross appearance
of sputum did not differ by sex, while women submitted
significantly lower volumes of sputum than men (me-
dian 2 ml vs. 3 ml; P= 0.001)(Table 2).
Kappa statistics
The kappa values were 0.75 for smear positivity, 0.57 for
disease extent, 0.64 for the presence of cavity on chest
radiograph, and 0.69 and 0.67 for gross appearance and
volume, respectively.
Predictors of smear positivity in male and female patients
with TB
Predictors of smear positivity differed by sex (Tables 3, 4
and 5). In male patients, the final model predicting
smear positivity included age, presence of hemoptysis,
duration of symptoms (≥3 weeks), presence of general
symptoms, presence of a cavity, and sputum gross ap-
pearance. However, sputum volume was not included.
Among them, duration of respiratory symptoms (odds
ratio (OR), 3.17, 95% confidence interval (CI), 1.29–
7.77), presence of a cavity on chest radiograph (OR,
3.50, 95% CI, 1.54–7.95), and sputum gross appearance
(purulent or blood-tinged sputum, rather than mucoid
or saliva; OR, 2.05, 95% CI, 1.21–3.47), showed signifi-
cant associations with smear positivity.
In women, the final model included the presence of
hemoptysis, duration of symptoms (≥3 weeks), presence
of general symptoms, gross appearance, and the volume
of sputum specimen. Among them, duration of








Age 43.1 ± 19.1 42.7 ± 18.2 44.1 ± 20.7 0.646
Body mass index 21.1 ± 2.8 19.3 ± 6.2 17.3 ± 9.0 0.148
Respiratory symptoms
any symptom 66.4% (113/170) 69.0% (78/113) 61.4% (35/57) 0.390
cough 55.9% (95/170) 58.4% (66/113) 50.9% (29/57) 0.414
sputum 40.6% (69/170) 44.2% (50/113) 33.3% (19/57) 0.189
hemoptysis 4.1% (7/170) 3.5% (4/113) 5.3% (3/57) 0.688
duration (weeks) 6.1 ± 14.0 5.3 ± 9.2 6.8 ± 19.8 0.499
General symptoms 30.6% (52/170) 34.5% (39/113) 22.8% (13/57) 0.081
Smoking
Current Smoker 32.9% (56/170) 45.1% (51/113) 8.8% (5/57) <0.001
Ex-smoker 22.9% (39/170) 24.8% (28/113) 19.3% (11/57) 0.448
Pack year 10.9 ± 15.6 13.5 ± 15.7 3.4 ± 12.0 <0.001
Radiographic extent
minimal 59.4% (101/170) 51.3% (58/113) 75.4% (43/57) 0.009
moderate 29.4% (50/170) 34.5% (39/113) 19.3% (11/57)
far-advanced 11.2% (19/170) 14.2% (16/113) 5.3% (3/57)
Cavity on chest radiograph 24.1% (41/170) 31.0% (35/113) 10.5% (6/57) 0.004
Smear positivity 42.9% (73/170) 46.0% (52/113) 36.8% (21/57) 0.325
Culture positivity 59.4% (101/170) 62.8% (71/113) 52.6% (30/57) 0.247
Note. ─ Numbers in parenthesis indicate the number of patients. TB tuberculosis.
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respiratory symptoms (OR, 4.83, 95% CI, 1.71–13.64),
gross appearance (purulent or blood-tinged sputum, ra-
ther than mucoid or saliva; OR, 2.78, 95% CI, 1.23–
6.26), and sputum volume (≥4 ml vs. <4 ml; OR, 4.96,
95% CI, 1.98–12.37) were significantly associated with
smear positivity in female patients. The results of uni-
variate and multivariate GEE analyses in all enrolled
patients regardless of sex are shown in the Additional
file 1: Appendix A-B.
Among the culture confirmed cases (n = 101; 71 male
patients and 30 female patients), BMI (≥23 vs. <23;
OR, 5.58, 95% CI, 1.51-20.64) and gross appearance of
sputum (purulent or blood-tinged sputum, rather than
mucoid or saliva; OR, 6.84, 95% CI, 3.12-15.01) were
significantly associated with smear positivity in male
patients on multivariate analyses. In female patients,
duration of respiratory symptoms (OR, 8.91, 95% CI,
2.76–28.81) and sputum volume (≥4 ml vs. <4 ml; OR,
7.99, 95% CI, 2.13–30.07) were significantly associated
with smear positivity. (Refer to Additional file 1:
Appendix C-E).
Impact of disease severity and smoking on volume of
sputum specimens in female patients with TB
In male patients, the presence of cavity (OR, 1.45, 95%
CI, 0.99–2.14) and amount of smoking (≥ 10 pack-years
vs. none; OR, 1.58, 95% CI, 1.02–2.46) were associated
with increased volume of submitted sputum. On con-
trary, neither presence of cavity, nor extent of disease,
nor amount of smoking were associated with volume of
submitted sputum in females.
Discussion
Through this prospective study, we showed that both
gross appearance and volume of sputum were associated
with smear positivity among female patients with pul-
monary TB. However, among male patients, only gross
appearance was a predictor of smear positivity.
The upgraded gross appearance of submitted sputum
in those suspected of TB was proposed to contribute to
the increase in smear positivity [3,4,6]. In addition, the
number of bacilli on smear positivity can be underesti-
mated in macroscopic poor-quality specimens [3,17,19].
Our study confirmed the importance of sputum gross
appearance. Nonetheless, even saliva-like sputum speci-
mens cannot be discarded because they could yield AFB
[20-22]. In our study, the AFB positivity of saliva was
not trivial (17.6%, 19 of 108).
Sputum volume (≥4 ml) was associated with smear
positivity in women, but not in men. Since women are
less proficient at expectoration than men [23,24], the
chance of expectorating proper sputum during attempts
to spit can increase in women with increasing requisite
sputum volume. The lack of association between









spot 36.1% (178/492) 35.3% (116/329) 38.0% (62/163)
morning 63.9% (314/492) 64.7% (213/329) 62.0% (101/163)
Sputum order 0.961
1st 34.5% (170/492) 34.3% (113/329) 35.0% (57/163)
2nd 34.5% (170/492) 34.3% (113/329) 35.0% (57/163)
3rd 31.0% (152/492) 31.4% (103/329) 30.0% (49/163)
Gross appearance 0.129
saliva 22.0% (108/492) 19.5% (64/329) 27.0% (44/163)
mucoid 42.3% (208/492) 41.6% (137/329) 43.6% (71/163)
purulent 33.3% (164/492) 36.2% (119/329) 27.6% (45/163)
blood-stained 2.4% (12/492) 2.7% (9/329) 1.8% (3/163)
Volume 0.001
<1 ml 22.0% (108/492) 17.6% (58/329) 30.7% (50/163)
1 ml≤<2 ml 27.6% (136/492) 27.1% (89/329) 28.8% (47/163)
2 ml≤<3 ml 25.6% (126/492) 27.4% (90/329) 22.1% (36/163)
3 ml≤<4 ml 14.0% (69/492) 17.0% (56/329) 8.0% (13/163)
4 ml≤<5 ml 7.3% (36/492) 7.9% (26/329) 6.1% (10/163)
≥ 5 ml 3.5% (17/492) 3.0% (10/329) 4.3% (7/163)
Note. ─ Numbers in parenthesis indicate the number of sputa.
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diseases severity/smoking and volume of sputum speci-
mens in females reflects their inferiority at expectoration
of sputum and reinforces the importance of volume of
submitted sputum. In contrast, the chance of expectorat-
ing proper sputum may be relatively constant in men,
regardless of the requisite volume, since they can more
easily expectorate proper sputum. This possibility is fur-
ther reinforced by the smear positivity trend being stag-
nant in men but increasing in women with increasing
sputum volume (data not shown). In fact, our result is in
accordance with a previous report that smear positivity
was increased substantially by provision of brief instruc-
tions, but only in females [4]. If available, sputum
induction or bronchoscopy can be used as an useful
technique to assess smear positivity in TB patients who
are unable to submit adequate sputum specimens [25].
Although setting a minimum volume of required spu-
tum for those suspected of TB has been reported to be
effective, no consensus exists as to how much is ad-
equate. Collection of 2, 3, or 5 ml of sputum has been
recommended, or tested as a surrogate for an adequate
sample [3-5,8,12,13], without detailed analysis. We tested
various volumes (1, 2, 3, 4, and 5 ml) to determine the
most appropriate minimum volume. Four milliliters was
the optimum minimal volume in female suspects. Spu-
tum volume was not associated with smear positivity in








40-59 years (versus < 40 years) 2.76 (1.24-6.14) 0.013 1.11 (0.32-3.89) 0.867
≥ 60 years (versus < 40 years) 1.03 (0.37-2.82) 0.961 2.45 (0.73-8.21) 0.146
BMI
≥23 (versus <23) 1.70 (0.71-4.10) 0.235 1.16 (0.39-3.42) 0.787
Respiratory symptoms
any symptom 3.73 (1.57-8.87) 0.003 3.85 (1.44-10.28) 0.007
cough 3.02 (1.42-6.42) 0.004 5.31 (2.03-13.92) 0.001
sputum 3.72 (1.78-7.77) <0.001 1.61 (0.56-4.63) 0.376
hemoptysis 2.26 (0.38-13.33) 0.369 7.96 (1.91-33.21) 0.004
duration (<3 weeks versus ≥3 weeks) 3.71 (1.77-7.78) 0.001 4.93 (1.83-13.30) 0.002
General symptoms 2.52 (1.19-5.37) 0.016 1.74 (0.44-6.94) 0.431
Smoking
current smoking 1.38 (0.68-2.81) 0.374 0.53 (0.14-2.09) 0.374
previous smoking 1.37 (0.63-2.98) 0.430 0.58 (0.14-2.40) 0.451
1-10 pack-years (versus 0 pack-years ) 1.85 (0.65-5.25) 0.250 0.58 (0.14-2,49) 0.464
≥ 10 pack-years (versus 0 pack-years ) 2.93 (1.22-7.07) 0.016 0.65 (0.18-2.36) 0.507
Radiographic extent
moderate or far-advanced (versus minimal) 4.42 (2.07-9.45) <0.001 1.23 (0.37-4.10) 0.732
cavity 5.27 (2.24-11.47) <0.001 2.02 (0.342-11.91) 0.438
Gross appearance of sputum specimens
sputum (versus saliva ) 1.70 (1.08-2.67) 0.021 1.51 (0.70-3.29) 0.297
purulent, bloody (versus saliva, mucoid) 2.04 (1.33-3.12) 0.001 2.96 (1.46-6.01) 0.003
Volume of sputum specimens
≥1 ml (<1 ml versus ≥1 ml) 1.18 (0.74-1.88) 0.482 2.81 (1.43-5.51) 0.003
≥2 ml (<2 ml versus ≥2 ml) 1.10 (0.87-1.39) 0.433 2.27 (0.99-5.17) 0.052
≥3 ml (<3 ml versus ≥3 ml) 1.12 (0.87-1.44) 0.396 1.74 (0.57-5.31) 0.331
≥4 ml (<4 ml versus ≥4 ml) 1.09 (0.90-1.32) 0.372 3.89 (1.89-7.98) <0.001
≥5 ml (<5 ml versus ≥5 ml) 1.01 (0.87-1.16) 0.933 3.31 (0.84-13.06) 0.088
Note. ─ CI confidence interval.
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a previous study, when the mean specimen volume was
4.0 ml or more [26].
Clinical and radiographic features were associated with
smear positivity. First, duration of respiratory symptoms
(>3 weeks) was associated with smear positivity in both
sexes. Longer symptom duration may reflect TB diagno-
sis at an advanced stage and so a higher bacilli load,
leading to a positive AFB smear [27,28]. However, in this
study, the presence of a cavity, a hallmark of high TB
burden [29], was associated with smear positivity only in
men. We are at present unable to explain why the pres-
ence of a cavity was not associated with smear positivity
among women. The relative rarity of cavities in females
(10.5%) may have hindered the proper evaluation of their
association with smear positivity.
Conclusions
Sputum specimen quality and volume were associated
with smear positivity. A volume of 4 ml was the
optimum minimum sputum volume acceptable for
smear microscopy in women suspected of having TB.
Those suspects of both sexes should be encouraged to
expectorate grossly qualified sputum specimens.
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hemoptysis 1.314 3.72 (0.76-18.19) 0.105
duration (<3 weeks
versus ≥3 weeks)
1.575 4.83 (1.71-13.64) 0.003
General symptoms 0.638 1.89 (0.40-9.01) 0.424
Gross appearance of sputum specimens
purulent, bloody
(versus saliva, mucoid)
1.021 2.78 (1.23-6.26) 0.014
Volume of sputum specimens
≥4 ml (<4 ml versus ≥4 ml) 1.600 4.96 (1.98-12.37) 0.001
Note. ─ CI confidence interval.
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